Evaluating Biopharma
Evaluating Biopharma
Latest Episodes
Preview: Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies
Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinberg, chief business development officer at Novo Nordisk Foundation Cellerat...
Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance
In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data provenance—why they matter and how the industry can achieve them. With 30 yea...
Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Chris Major, founder and partner of BioProcess360 Partners, discuss the best ways to start a company to address technology gaps, why it is beneficial to collaborate with compe...
Episode: 21 - How AI is Changing the Antibody R&D Game
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Tony Arulanandam, SVP and head of R&D at Cytovia Therapeutics, discuss how AI is impacting the antibody R&D field, how companies are using AI to generate better sequen...
Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix
In this month’s special episode of Evaluating Biopharma, host Ben Locwin interviews Mara Strandlund, chief people officer at National Resilience, and Niamh Alix, chief human resources officer at Prime Medicine, about the upcoming Talent in Biop...
